9 October 2026 in Medicine
Background: Cataract remains the leading cause of reversible blindness worldwide, particularly in low-resource settings. Effective control of postoperative inflammation is essential to prevent complications such as cystoid macular edema and raised intraocular pressure. Dexamethasone and Triamcinolone acetonide (TCA) are widely used corticosteroids; however, their comparative efficacy remains uncertain. This updated systematic review and meta-analysis aimed to compare their effectiveness following cataract surgery. Methods: A systematic search of 4 databases (PubMed, Google Scholar, Cochrane Central Library and Scopus) was conducted up to June 2026 following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (International Prospective Register of Systematic Reviews: CRD420261435380). Randomized controlled trials and prospective studies comparing dexamethasone and TCA in adults undergoing phacoemulsification were included. Risk of bias was assessed using cochrane risk of bias 2 and the Newcastle–Ottawa Scale. Certainty of evidence was evaluated using grading of recommendations assessment, development and evaluation. A random-effects model was used, with heterogeneity assessed by I 2 . Results: Twelve studies (nine randomized controlled trials and 3 non-randomized prospective studies; n = 2003) were included. No significant differences were observed in intraocular pressure (Mean Difference, mm Hg) at any time point up to 3 months. Visual acuity showed modest improvement with TCA at 7 and 28/30 days, though results were inconsistent on sensitivity analysis. No significant differences were found in anterior chamber flare or cells across all time points. A nonsignificant trend toward greater endothelial cell loss was observed with dexamethasone. Overall, evidence certainty was low. Conclusion: Dexamethasone and TCA demonstrate comparable efficacy and safety in controlling postoperative inflammation after cataract surgery. TCA may offer short-term visual benefits and prolonged action, whereas dexamethasone allows flexible dosing. Clinical decisions should be individualized, considering patient compliance and clinical context.
6 November 2026 in Langenbeck's Archives of Surgery
Background: The optimal management of medial epicondyle fractures remains controversial, particularly in displaced fracture without incarceration. Traditionally, non-surgical treatment remains the treatment of choice for the management of medial epicondyle fracture; however recent evidence suggesting favorable outcomes with surgical fixation has increased interest in operative management. This systematic review and meta-analysis aimed to compare surgical versus non-surgical treatment for the management of medial epicondyle fracture in pediatric population to determine the optimal management therapy. Methods: A systematic search of PubMed, Cochrane Library, and Google Scholar and Clinical trial govt. was conducted from inception to April 2026 according to PRISMA guidelines (PROSPERO: CRD420261393871 ) . Randomized controlled trials and observational studies were included. Statistical analyses were performed using a random-effects model in RevMan 5.4. Risk of bias was evaluated using the Cochrane RoB 2 tool and Newcastle–Ottawa Scale, while certainty of evidence was assessed using GRADE. Results: Six comparative studies involving 564 pediatric patients were included, comprising two randomized controlled trials and four cohort studies. Surgical fixation significantly reduced the risk of non-union (RR = 0.09, 95% CI: 0.02–0.39; p = 0.001) and worse cosmetic VAS scores (MD = − 8.56, 95% CI: −12.66 to − 4.46; p < 0.0001), favoring non-surgical management. However, surgery was associated with a significantly greater likelihood of requiring additional surgery (RR = 13.37, 95% CI: 5.20–34.35; p < 0.00001). No significant differences were observed between groups for DASH scores, elbow flexion or extension deficits, PedsQL scores, or valgus instability tests. Conclusion: Surgical treatment reduces nonunion but is associated with worse cosmetic outcomes in pediatric medial epicondyle fracture. However, its effect on functional outcomes remains uncertain compared with non-surgical treatment. Treatment decisions should therefore be individualized based on clinical and patient-specific factors.